BBIO - BridgeBio Pharma, Inc.
IEX Last Trade
27.63
-0.515 -1.864%
Share volume: 13,472
Last Updated: Fri 27 Dec 2024 05:30:23 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$28.14
-0.52
-1.83%
Summary score
31%
Profitability
37%
Dept financing
25%
Liquidity
73%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-4.69%
Return on assets
-17.68%
Return on sales
-15000.49%
Return on invested capital
400.81%
Total debt ratio
224.71%
Debt ratio change over timeo
0.33%
Current Ratio
6.1%
Quick Ratio
6.1%
Cash Position Ratio
5.52%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
9.29%
Return on assets
-19.66%
Return on sales
-5574.77%
Return on invested capital
139.97%
Total debt ratio
273.34%
Debt ratio change over timeo
0.92%
Current Ratio
4.75%
Quick Ratio
4.75%
Cash Position Ratio
3.79%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
6.72%
Return on assets
-22.73%
Return on sales
-8329.01%
Return on invested capital
-167.8%
Total debt ratio
237.58%
Debt ratio change over time
-2.42%
Current Ratio
4.59%
Quick Ratio
4.59%
Cash Position Ratio
3.33%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-95.27%
Return on assets
-107.21%
Return on sales
1015.42%
Return on invested capital
-3.41%
Total debt ratio
33.18%
Debt ratio change over time
0.33%
Current Ratio
1.37%
Quick Ratio
1.37%
Cash Position Ratio
1.17%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BBIO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.69% | 15.05% | 35.64% | 7.13% |
| Return on assets | -17.68% | 2.88% | 3.13% | 5.53% |
| Return on sales | -15000.49% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 400.81% | 2.57% | 5.37% | 18.48% |
| Profitability | 25% | 42% | 59% | 56% |
| Total debt ratio | 224.71% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | 0.33% | 326.95% | -8.44% | 1.18% |
| Dept financing | 25% | 35% | 10% | 3% |
| Current Ratio | 4.75% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 4.75% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.79% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 8% | 18% | 45% |
| Short-term ratios | BBIO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 9.29% | 13.14% | 10.88% | 4.07% |
| Return on assets | -19.66% | 2.1% | 1.54% | 3.03% |
| Return on sales | -5574.77% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 139.97% | 1.95% | 2.74% | 9.55% |
| Profitability | 43% | 61% | 49% | 59% |
| Total debt ratio | 273.34% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | 0.92% | 51.04% | -101.54% | 1.43% |
| Dept financing | 25% | 33% | 9% | 3% |
| Current Ratio | 4.75% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 4.75% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.79% | 0.39% | 1.05% | 2.91% |
| Liquididy | 72% | 11% | 24% | 69% |